
ARC 239 dihydrochloride
CAS No. 55974-42-0
ARC 239 dihydrochloride( ARC-239 | ARC239 )
Catalog No. M15036 CAS No. 55974-42-0
A potent, selective α2B adrenoceptor antagonist with pKd of 8.8, 200-fold selectivity over α2A, and α2D receptors.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 68 | Get Quote |
![]() ![]() |
10MG | 120 | Get Quote |
![]() ![]() |
25MG | 255 | Get Quote |
![]() ![]() |
50MG | 410 | Get Quote |
![]() ![]() |
100MG | 591 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameARC 239 dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective α2B adrenoceptor antagonist with pKd of 8.8, 200-fold selectivity over α2A, and α2D receptors.
-
DescriptionA potent, selective α2B adrenoceptor antagonist with pKd of 8.8, 200-fold selectivity over α2A, and α2D receptors; competitively antagonizes pressor responses to adrenaline and inhibits pressor responses to noradrenaline, phenylephrine, tyramine, and dimethylphenylpiperazinium in rats and dogs.
-
In Vitro——
-
In Vivo——
-
SynonymsARC-239 | ARC239
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
RecptorAdrenergic Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55974-42-0
-
Formula Weight480.43
-
Molecular FormulaC24H29N3O3.2HCl
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (260.18 mM)
-
SMILESCC1(C2=CC=CC=C2C(=O)N(C1=O)CCN3CCN(CC3)C4=CC=CC=C4OC)C.Cl.Cl
-
Chemical Name2-[2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mouillé P, et al. J Cardiovasc Pharmacol. 1980;2(2):175-91.
2. Bylund D, et al. J Pharmacol Exp Ther. 1988 May;245(2):600-7.
3. Bylund DB, et al. J Pharmacol Exp Ther. 1989 Nov;251(2):640-4.
molnova catalog



related products
-
Dabuzalgron
Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.
-
Dihydrochelerythrine
Dihydrochelerythrine is nontoxic up to 5μM concentration. Dihydrochelerythrine has antifungal activity against pathogenic plant fungi.
-
nifenalol.HCl
Nifenalol is a antagonist of β-adrenergic receptor.